We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.  
days to go: Expired investment: £575,000
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go: Expired investment: £1,146,318
We are a property Market Place matching Buyers and Sellers, Landlords and Tenants without the use of estate agents. The online portal will dramatically reduce the fees that sellers and landlords pay agents to find buyers and tenants for their properties
days to go: Expired investment: Withheld
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go: Expired investment: £543,670
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
Brickowner is a service provider for property developers and asset managers wanting to improve the cost and efficiency of onboarding and managing investors. The company undertakes crucial tasks related to property transactions such as Anti Money Laundering (AML), Know Your Client (KYC), investor categorisation, and escrow requirements for its clients. These tasks take a lot of time and money through regular offline channels, but the company speeds up this process by taking it online. In 2017, a sum of £348,000 was invested through the company's platform which by January 2020 had reached over £12 million. The company has over 2400 investors registered on its platform wherein 630+ investors have invested in substantial investments. It has been featured in prominent publications such as Daily Mail, Property Week, London Evening Standard, and The Week. The company will use the investment aims to cover capital costs to support growth such as hiring, develop new technology to increase product availability, marketing strategy, and increase the technical capacity of the platform.
days to go: Expired investment: £397,840
An automated platform allowing landlords to manage their properties and save time and money on fees. With brightLET's solution, there is no need for an intermediary person to be involved in the property management process. Landlords can perform administration tasks on their own tenancies, be kept up-to-date on ever-changing regulations and manage tradespeople. Specific services available to landlords include options to book viewings, upload photos, videos and floorplans, provide reports on inspections, gas safety, EPC, Right 2 Rent and PAT checks. The brightLET platform is available on almost any device, including desktops, tablets and mobile devices. brightLET has partnered with the YMCA, this has allowed the company access to a provider market and housing association worth more than £10bn. There are various user types utilising the platform, since launch 650+ landlords, 1000+ tenants and 300+ tradespeople are using brightLET to manage their properties. Their revenue model has resulted in landlords achieving savings on property fees of £450 outside London and £1,368 within London. Funds will primarily be used for growth and expansion within London, as this is where the majority of brightLET landlords are situated. The company aims to increase their brand awareness through marketing campaigns and hire talent to assist with technology developments, sales and customer support.
days to go: Expired investment: £66,932
An easy and simple app for university students to find properties and pay rent all from the comfort of their own sofa. Bubble Student already has information for over 200,000 rooms, which users can book viewing schedules for, as well as a group chat feature to easily discuss the property with their friends.
days to go: Expired investment: £430,320
CapitalRise is an online property lending platform offering market-leading returns of 7-12% per annum from secured lending to prime real estate. Till date, the company has lent £71.9 million against assets worth over £410 million, repaid £28 million of capital and return to customers, and saw a 354% increase in revenues in 2019. CapitalRise is ranked #1 in both 1-year and 3-year net returns as verified by leading loan analytics firm, Brismo. The company has won awards including, the British Bank Awards 2020 - Best Alternative Finance Provider. It has also received press coverage from publications such as The Times, Forbes and Daily Express. It will use the investment to take advantage of the UK government's Future Fund given the positive feedback from its investors, improve its technology platforms, further its marketing and lending initiatives, and satisfy customer expectations.
days to go: Expired investment: £2,214,280
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
days to go: Expired investment: £520,294
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph